Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CTNM compared with BNTC: revenue, margins and what each company keeps, and the suppliers and customers both name
CTNM
Contineum Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
BNTC
Benitec Biopharma Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CTNM
Contineum Therapeutics, Inc.
vs
BNTC
Benitec Biopharma Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
CTNM: latest quarter not drawable. BNTC: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CTNM, solid
BNTC, dashed
CTNM
Contineum Therapeutics, Inc.
Change
9.40
▲
+0.70%
· post 9.39
Mkt cap
$353.3M
Revenue
—
BNTC
Benitec Biopharma Inc.
Change
8.77
▼
−0.67%
· post 8.77
Closed
Oct 30 '26
Mkt cap
$304.9M
Revenue
$7,000
Q4 FY23
vs
Compare
Closed
Oct 30 '26
CTNM
Contineum Therapeutics, Inc.
vs
BNTC
Benitec Biopharma Inc.
9.40
▲
+0.70%
post 9.39
Price
8.77
▼
−0.67%
post 8.77
$353.3M
Mkt cap
$304.9M
—
Revenue
$7,000
Q4 FY23
Change
Change
CTNM
9.40
▲
+0.70%
vs
BNTC
8.77
▼
−0.67%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CTNM
2
JNJ
J&J
customer
—
WuXi AppTec
unlisted
supplier
Shared
0
No shared counterparties.
Only BNTC
2
—
Australian government
unlisted
supplier
—
Axovant Therapeutics
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR